<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Six patients with an aggressive <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> disorder had a t(14;18) as well as either a t(8;14) (three patients) or a t(8;22) (three patients) </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001909'>Leukemia</z:hpo> cells from <z:hpo ids='HP_0000001'>all</z:hpo> three patients with the t(8;22) had a mature B <z:mp ids='MP_0005384'>cell phenotype</z:mp> (Smlg + and TdT-), whereas two of three patients with the t(8;14) had a pre-B phenotype and were Smlg- </plain></SENT>
<SENT sid="2" pm="."><plain>None of the patients with the t(8;22) had a prior history of follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, whereas two of the three patients with the t(8;14) had had a follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The clinical, cytogenetic, and morphologic characteristics of these six patients along with eight previously reported cases with both the t(14;18) and the t(8;14), the t(8;22) or the t(2;8) are discussed </plain></SENT>
</text></document>